Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam and Clonidine in Fecal Incontinence
NCT02628626Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2015
- Primary completion
- Apr 2022
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colesevelam, Clonidine Lauriad in fecal incontinence (FI), sponsored by Mayo Clinic. Started Nov 2015; status: completed.
02
Drugs
colesevelamClonidine Lauriad
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT02628626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628626.